Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Ironwood Pharmaceuticals (IRWD) Long-Term Debt Issuances (2017 - 2023)

Ironwood Pharmaceuticals (IRWD) has disclosed Long-Term Debt Issuances for 4 consecutive years, with $400.0 million as the latest value for Q2 2023.

  • Quarterly Long-Term Debt Issuances changed N/A to $400.0 million in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $400.0 million through Dec 2024, changed 0.0% year-over-year, with the annual reading at $150.0 million for FY2024, 62.5% down from the prior year.
  • Long-Term Debt Issuances hit $400.0 million in Q2 2023 for Ironwood Pharmaceuticals, up from $146.2 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $400.0 million in Q2 2023 to a low of $400.0 million in Q2 2023.